UK Markets closed for Early May Bank Holiday

Hikma Pharmaceuticals PLC (HIK.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
1,944.06-21.94 (-1.48%)
At close: 5:10PM BST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous close1,966.00
Bid1,850.00 x 16300
Ask2,350.00 x 34600
Day's range1,931.00 - 1,971.00
52-week range1,575.00 - 2,703.00
Avg. volume658,391
Market cap4.66B
PE ratio (TTM)29.37
Earnings dateN/A
Dividend & yield0.22 (0.93%)
Ex-dividend date2016-09-01
1y target estN/A
  • Reuters - UK Focus5 days ago

    New GlaxoSmithKline CEO wants fewer, bigger new drug launches

    GlaxoSmithKline (Other OTC: GLAXF - news) 's new chief executive aims to improve returns in drug development, and wants fewer but bigger new medicine launches. In her first comments since taking over on April 1, Emma Walmsley, 47, said on Wednesday that her priority was the pharmaceuticals unit, where she wants commercial considerations to be given greater weight in early investment decisions. "We'd like to have probably fewer and more focused priorities, to have bigger launches," she told reporters, after announcing first-quarter results, adding this would involve tough choices and the closure of some research programmes.

  • Reuters - UK Focus5 days ago

    Weak sterling boosts GlaxSmithKline as new CEO takes over

    GlaxoSmithKline's new chief executive reported slightly better than expected first-quarter results on Wednesday, keeping the drugmaker on track to hit financial targets in 2017 as it braces for generic ...

  • MarketWatch23 days ago

    Time for some game theory: A look at Jazz Pharma’s latest settlement

    Shares surged 7.6% on the news, but the devil’s in the details.